Kalpit Patel

Stock Analyst at B. Riley Securities

(0)
# 4419
Out of 5,270 analysts
65
Total ratings
30.56%
Success rate
-11.54%
Average return
23 Stocks
Name Action Price Target Current % Upside Ratings Updated
Geron
Maintains: Buy
6 4
1.75 100% 3 Feb 18, 2025
Verastem
Maintains: Strong Buy
7 9
5.58 61.29% 4 Jan 31, 2025
Foghorn Therapeutics
Initiates Coverage On: Buy
10
4.3 132.56% 1 Jan 30, 2025
Bicycle Therapeutics
Maintains: Neutral
28 17
10.5 61.9% 6 Dec 13, 2024
Rigel Pharmaceutical...
Maintains: Neutral
27 20
22.5 -11.11% 5 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 7
1.24 464.52% 5 Nov 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
45 60
n/a n/a 4 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
85 40
6.85 483.94% 2 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
31 36
30.05 19.8% 2 Jul 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 3
0.5 500% 2 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 20
14.57 37.27% 3 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3 1
0.37 170.27% 1 Dec 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
65 60
n/a n/a 5 Oct 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6
5.29 13.42% 5 Sep 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
34 36
15.62 130.47% 2 Jul 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3 2
n/a n/a 1 Nov 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
9 3
0.26 1053.85% 3 Nov 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
21 18
1.8 900% 2 Sep 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 5
1.96 155.1% 2 Jul 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
240 120
0.82 14534.15% 2 Jun 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
24 10
8.81 13.51% 1 Jan 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
208 96
n/a n/a 2 Jan 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
75
8.6 772.09% 2 Sep 3, 2021